The impact of PROgnostic SIgnatures in stage II colon cancer patients…
Researchers identified an immune signature in stage II colon cancer that predicts worse outcomes, offering a path to identify patients who might benefit from intensified treatment.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate…
A combination of marine-derived compounds showed promise in slowing kidney disease progression and improving cholesterol in diabetic patients over 12 weeks.
Standard additionReference frequencies of selected non-ICI genomic alterations…
Japan's nationwide genomic study creates a reference guide for genetic changes in routine cancer testing, helping doctors better interpret test results.
Standard additionLocal ablative treatment for oligoprogression during immunotherapy in…
Adding localized cancer treatments to immunotherapy showed signs of extending survival in advanced lung cancer, though more rigorous studies are needed.
Standard additionSocial and Environmental Exposures and the Developing Gut of Newborns…
Feeding methods and socioeconomic factors shape newborn gut microbiomes in heart disease, suggesting intervention opportunities early in life.